Filing Details

Accession Number:
0001493152-21-015620
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-29 19:42:09
Reporting Period:
2021-06-28
Accepted Time:
2021-06-29 19:42:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1444307 Oncosec Medical Inc ONCS Pharmaceutical Preparations (2834) 980573252
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1652973 A Brian Leuthner 24 North Main Street
Pennington NJ 08534-2218
Interim Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-28 192,000 $0.00 192,000 No 4 A Direct
Common Stock Disposition 2021-06-28 13,613 $3.16 178,387 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2021-06-28 33,000 $0.00 33,000 $3.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
33,000 2021-06-28 2031-06-28 No 4 A Direct
Footnotes
  1. Reflects restricted stock units (RSUs) that were 25% vested upon grant with the remaining 75% vesting in equal quarterly installments over the next two years.
  2. In connection with the vesting of 48,000 RSUs on June 28, 2021, a total of 13,613 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies.
  3. The option is 25% vested upon grant with the remaining 75% vesting in equally in quarterly installments over the next two years.